GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Price-to-Free-Cash-Flow

TCM Biotech International (ROCO:4169) Price-to-Free-Cash-Flow : N/A (As of Jun. 20, 2024)


View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Price-to-Free-Cash-Flow?

As of today (2024-06-20), TCM Biotech International's share price is NT$55.60. TCM Biotech International's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.79. Hence, TCM Biotech International's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for TCM Biotech International's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 13 years, TCM Biotech International's highest Price-to-Free-Cash-Flow Ratio was 296.48. The lowest was 24.13. And the median was 158.43.

ROCO:4169's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.435
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

TCM Biotech International's Free Cash Flow per Share for the six months ended in Dec. 2023 was NT$-0.55. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was NT$-0.79.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of TCM Biotech International was -183.70% per year.

During the past 13 years, TCM Biotech International's highest 3-Year average Free Cash Flow per Share Growth Rate was 27.50% per year. The lowest was -24.40% per year. And the median was 1.55% per year.


TCM Biotech International Price-to-Free-Cash-Flow Historical Data

The historical data trend for TCM Biotech International's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Price-to-Free-Cash-Flow Chart

TCM Biotech International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 32.22 240.15 30.72 -

TCM Biotech International Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 240.15 - 30.72 - -

Competitive Comparison of TCM Biotech International's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, TCM Biotech International's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TCM Biotech International's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TCM Biotech International's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where TCM Biotech International's Price-to-Free-Cash-Flow falls into.



TCM Biotech International Price-to-Free-Cash-Flow Calculation

TCM Biotech International's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=55.60/-0.789
=N/A

TCM Biotech International's Share Price of today is NT$55.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TCM Biotech International's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$-0.79.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

TCM Biotech International  (ROCO:4169) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


TCM Biotech International Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


TCM Biotech International (ROCO:4169) Business Description

Traded in Other Exchanges
N/A
Address
No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221
TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International (ROCO:4169) Headlines

No Headlines